New Member Spotlight: BSI Medical Devices

We warmly welcome BSI as a new member of our life science park, located in our co-working space in The Spark building!

BSI Medical Devices offers certification services to help place safe and compliant medical devices on the market. As independent, market-leading experts in patient safety, we enable effective market access for medical technologies.

We asked Magnus Olla, Senior Business Development Manager, Medical Devices & IVD – Nordics, to answer three key questions and share insights into how BSI Medical Devices aims to make a difference in our community and the industry in our region.

How can the life science community in southern Sweden benefit from your membership at Medicon Village?

Medicon Village represents excellence in the MedTech and healthcare landscape and drives continuous innovation through its own activities. As a full-scope Notified Body and full-scope Approved Body, joining this environment is a natural step for us.

By becoming part of this community, we aim to embark on a collaborative journey with its stakeholders. We want to share information, insights and experience that help strengthen an ecosystem which supports company growth, technological innovation, and improved outcomes for patients and society.

Our mission is clear: as independent, market-leading experts in patient safety, we enable effective market access for medical technologies. The life science community will benefit from our presence in several ways:

• Significant value for manufacturers and start-ups. The role BSI can play within this community brings substantial value, especially for early-stage companies seeking market access. Access to timely regulatory insights, clear expectations and guidance can help these organisations navigate the conformity pathway more effectively.
• Regulatory excellence at the heart of the ecosystem. We are dedicated to upholding the quality, safety and performance of medical devices and IVDs, providing early guidance that empowers innovators to navigate complex regulatory pathways.
• Proven leadership and deep experience. BSI is recognised as a leading Notified Body and UK Approved Body. This extensive experience gives Medicon Village members access to informed, practical and timely regulatory expertise.
• A transparent, predictable and reliable partner. Our commitment to transparent and consistent processes helps reduce uncertainty for manufacturers and supports more efficient preparation for conformity assessment. We were the first Notified Body to publish conformity assessment lead times for MDR, IVDR and UKCA. This demonstrates our commitment to transparency and to improving predictability in the certification process.

BSI’s membership contributes to a stronger, more connected and better-informed MedTech ecosystem in southern Sweden, accelerating innovation and helping ensure that safe, high-quality medical technologies reach patients faster.

As part of our commitment to knowledge sharing, BSI offers white papers and webinars that provide clear insight into certification expectations and the technical requirements of MDR and IVDR, helping manufacturers navigate the regulatory process with confidence.

What is your perspective on the opportunities for the Swedish life science industry to strengthen its international relations?

Sweden has a long tradition of research and development in life science, supported by a well-functioning ecosystem that encourages collaboration, innovation and continuous progress. It is widely recognised for its strong track record of innovation and excellence, both in Europe and worldwide.

It is vital for companies to build strong business models and go-to-market strategies from day one in order to succeed internationally. An early focus on market access ensures that products are designed and developed with regulatory requirements and market expectations in mind, reducing delays and costly revisions later. Clear regulatory planning – including a thorough understanding of Notified Body expectations – allows manufacturers to align their technical documentation, clinical evidence and quality systems with European and global standards.

This proactive approach not only streamlines the certification process but also strengthens a company’s credibility and competitiveness in international markets.

BSI is able to provide transparent information on certification expectations and regulatory technical requirements. Our Structured Dialogue gives manufacturers the opportunity to gain a better understanding of the conformity assessment processes for medical devices and IVDs carried out by Notified Bodies. It may outline the key steps in the application process, describe conformity assessment procedures, and highlight the most important elements of a manufacturer’s compliance evidence.

What are your major challenges in the coming year to meet market demands and trends?

Ensuring that manufacturers clearly understand the regulatory landscape and Notified Body expectations is essential.

As a Notified Body, BSI understands the challenges manufacturers face in bringing compliant products to market efficiently and safely, especially start-ups and SMEs that are still adapting to the requirements of MDR and IVDR. Globally, more than 86% of the manufacturers we work with across all regulatory certification services are SMEs, of which 11% are start-ups.

BSI is committed to supporting innovation while ensuring safety and compliance. We continue to invest in resources and expertise worldwide to help manufacturers access efficient pathways to market. We accept MDR, IVDR and UKCA applications with no restrictions.

Want to know more about BSI?

There will be an opportunity to meet BSI on 27 January, when they host our Science for Breakfast at Medicon Village. More information and sign up is available in the Event Calendar on our website.

For more information about BSI, please visit the BSI website or the BSI member profile on our website including contact information for Magnus Olla.